Acute Lymphoblastic Leukemia
Monitoring of TCR or immunoglobulin genes improves disease management
Published in Hematology Week, July 7th, 2003
According to a study from Germany, "Today, 80% of pediatric patients with acute lymphoblastic leukemia (ALL) can be cured. To reduce the rate of relapses, but also to limit treatment morbidity, risk-adapted treatment has been attempted after identifying the most specific prognostic factors.
"In addition to clinical factors (e.g. age, WBC), immunophenotype, and cytogenetic results, the early in vivo treatment response as determined by cytology had evolved as the most important...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
Source: Hematology Week (2003-07-07)
More Articles from Hematology Week
- Chronic Myeloid Leukemia
Filgrastim safe for stem cell mobilization during imatinib treatment - Hematology
Murine embryos defective for angiogenesis yield hematopoiesis information - Occupational Disease
New guidelines for occupational exposure to blood-borne virus released - Thrombocytopenia Purpura
Increased serum immunoglobulins at onset can be predictive of the acute form - Chronic Lymphocytic Leukemia
Stem cell allografts effective after reduced-intensity conditioning - Diagnostics
Increase in serum CA125 is a possible marker for epithelioid sarcoma - More from this issue of Hematology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
